Methods for volume assessment of prostate cancer

European Radiology

Volumn 14, Issue 4, 2004, Pages 597-606

  Schlemmer, Heinz Peter ^a   Corvin, Stefan ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

MR imaging; Prostate carcinoma; Tumor volume; Ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; CONTRAST ENHANCEMENT; ECHOGRAPHY; ELASTOGRAPHY; FEASIBILITY STUDY; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; MALE; MEDICAL TECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME;

HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 1842555332     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2233-4     Document Type: Review

References (74)

1. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics. CA Cancer J Clinc 49:8-31, 1
2. Mettlin CJ, Murphy GP, Rosenthal DS, Menck HR (1999) The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the US. The American College of Surgeons Commissions on Cancer and the American Cancer Society. Cancer 83:1679-1684
3. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long-term biochemical disease free survival and cancer specific survival following anatomic radical prostatectomy. Urol Clin North Am 28:555-565
4. Humphrey PA, Frazier HA, Vollmer RT, Paulson DF (1993) Stratification of pathological features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels. Cancer 71:1821-1827
5. Humphrey PA, Walter PJ (1993) Adenocarcinoma of the prostate. Part II. Tissue prognosticators. Am J Clin Pathol 100:256-269
6. Epstein JI, Pizov G, Walsh PC (1993) Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71:3582-3593
7. Egevad L, Norberg M, Mattson S, Norlen BJ, Busch C (1998) Estimation of prostate cancer volume by multiple core biopsies before radical prostatectomy. Urology 52:653-658
8. McNeal JE (1992) Cancer volume and site of origin of adenocarcinoma of the prostate: Relationship to local and distant spread. Hum Pathol 23:258-266
9. Babaian RJ, Troncoso P, Steelhammer LC, Lloreta-Trull J, Ramirez EI (1995) Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. J Urol 154:1808-1812
10. Bostwick DG, Graham SD, Napalkov P, Abrahamsson PA, Sant'Agnese PA, Algaba F, Hoisaeter PA, Lee F, Littrup P, Mostofi FK, Denis L, Schroeder F, Murphy GP (1993) Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41:403-411
11. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM (1999) Biological determinants of cancer progression in men with prostate cancer. JAMA 281:1395-1400
12. Salomon L, Levrel O, Anastasiadis AG, Irani J, de la Taille A, Saint F, Vordos D, Cicco A, Hoznek A, Chopin D, Abbou CC (2003) Prognostic significance of tumor volume after radical prostatectomy: A multivariant analysis of pathologic prognostic factors. Eur Urol 43:39-44
13. Epstein JI, Carmichael M, Partin AW, Walsh PC (1993) Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariant analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow up. J Urol 149:1478-1481
14. Miller GJ (1989) Pathologic aspects of prostate cancer: prediction of malignant potential. Urology 34[Suppl 4]: 5-9
15. Miller GJ, Cygan JM (1994) Morphology of prostate cancer: The effect of multifocality on histological grade, tumor volume and capsule penetration. J Urol 152:1709-1713
16. Epstein JI, Carmichael MJ, Partin AW, Walsh PC (1994) Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: Pathogenetic and clinical importance. J Urol 151:1587-1592
17. Hirano D, Werahera PN, Crawford ED, Lucia MS, DeAntoni EP, Miller GJ (1998) Morphological analysis and classification of latent prostate cancer using a 3-dimensional computer algorithm: Analysis of tumor volume, grade, tumor doubling time and life-expectancy. J Urol 159:1265-1269
18. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC (1990) Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 143:747-752
19. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB (1995) Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274:1214-1220
20. Grossklaus DJ, Smith JA, Shappell SB, Coffey CS, Chang SS, Cookson MS (2002) The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA. Urol Oncol 7:195-198
21. Grossklaus DJ, Coffey CS, Shappell SB, Jack GS, Chang, SS, Cookson MS (2002) Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol 167:2032-2036
22. Daneshgari F, Taylor GD, Miller GJ, Crawford ED (1995) Computer simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsies. Urology 45:604-609
23. Loughlin M, Carlbom I, Busch C, Douglas T, Egevad L, Frimmel H, Norberg M, Sesterhenn I, Frogge JM (1998) Three-dimensional modeling of biopsy protocols for localized prostate cancer. Comput Med Imaging Graph 22:229-238
24. Egevad L, Frimmel H, Norberg M, Mattson S, Carlbom I, Bengtsson E, Busch C (1999) Three-dimensional computer reconstruction of prostate cancer from radical prostatectomy specimens: Evaluation of the model by core biopsy simulation. Urology 53:192-198
25. Jager GJ, Ruijter ETG, van de Kaa, CA, de la Rosette JJMCH, Ooosterhof GON, Thornbury JR, Barentz JO (1996) Local staging of prostate cancer with endorectal MR imaging: Correlation with histopathology. Am J Roentgenol 166:845-852
26. Ponchietti R, Di Loro F, Fanfani A, Amorosi A (1999) Estimation of prostate cancer volume by endorectal coil magnetic resonance imaging pathologic volume. Eur Urol 35:32-35
27. Pirtskhalaishvili G, Hrebinko RL, Nelson JB (2001) The treatment of prostate cancer. An overview of current options. Cancer Pract 9:295-306
28. Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC (1989) Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 141:341-345
29. Hendrikx A, van Helvoort-van Dommelen C, van Dijk MA, Reintjes AG, Debruyne FM (1989) Ultrasonic determination of prostatic volume: A cadaver study. Urology 34:123-125
30. Aarnink R, de la Rosette J, Debruyne F, Wijkstra H (1996) Formula-derived prostate volume determination. Eur Urol 29:399-402
31. Aarnink R, Giesen R, de la Rosette J, Huynen A, Debruyne F, Wijkstra H (1995) Planimetric volumetry of the prostate: How accurate is it? Physiol Meas 16:141-150
32. Augustin H, Graefen M, Palisaar J, Blonski J, Erbersdobler A, Daghofer F, Huland H, Hammerer P (2003) Prognostic significance of visible lesions on transrectal ultrasound in impalpable prostate cancers: implications for staging. J Clin Oncol 21:2860-2868
33. Shinohara K, Wheeler T, Scardino P (1989) The appearance of prostate cancer on transrectal ultrasonography. Correlation of imaging and pathological examinations. J Urol 142:76-82
34. Terris M, McNeal J, Stamey T (1992) Estimation of prostate cancer volume by transrectal ultrasound imaging. J Urol 147:855-857
35. Kojima M, Troncoso P, Babaian RJ (1995) Use of prostate-specific antigen and tumor volume in predicting needle biopsy grading error. Urology 45:807-812
36. Okihara K, Watanabe H (1994) Kinetic analysis of focal hypoechoic lesions in the prostate treated by castration. Prostate 24:252-256
37. Watanabe H, Kojima M (1997) The role of prostatic planimetry using transrectal sonography in prostatic diseases. Semin Surg Oncol 13:425-430
38. Shigeno K, Igawa M, Shiina H, Wada H, Yoneda T (2000) The role of colour doppler ultrasonography in detecting prostate cancer. BJU Int 86:229-233
39. Halpern E, Frauscher F, Strup S, Nazarian L, O'Kane P, Gomella L (2002) Prostate: High-frequency Doppler US imaging for cancer detection. Radiology 225:71-77
40. Bogers HA, Sedelaar JP, Beerlage HP, de la Rosette JJ, Debruyne FM, Wijkstra H, Aarnink RG (1999) Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 54:97-104
41. Pepe P, Patane D, Panella P, Aragona F (2003) Does the adjunct of ecographic contrast medium Levovist improve the detection rate of prostate cancer? Prostate Cancer Prostatic Dis 6:159-162
42. Bezzi JI, Kressel HY, Allen KS, Schiebler ML, Altman HG, Wein AJ, Pollack HM (1988) Prostrate carcinoma: Staging with MR imaging at 1.5 T. Radiology 169:339-346
43. Kahn T, Bürrig K, Schmitz-Drager B, Lewin JS, Furst G, Modder U (1989) Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation. Radiology 173:847-851
44. McSherry SA, Levy F, Schiebler ML, Keefe B, Dent GA, Mohler JL (1991) Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: Comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging. J Urol 146:85-89
45. Quint LE, van Erp JS, Bland PH, Mandell SH, del Buono EA, Grossman HB, Glazer GM, Gikas PW (1999) Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume. Am J Roentgenol 156:511-516
46. Outwater E, Schiebler ML, Tomaszewski JE, Schnall MD, Kressel HY (1992) Mucinous carcinomas involving the prostate: Atypical findings at MR imaging. J Magn Reson Imaging 2:597-600
47. Sommer FG, Hghiem HV, Herfkens R, McNeal JE, Low RN (1993) Determining the volume of prostatic carcinoma: Value of MR imaging with an external array coil. Am J Roentgenol 161:81-86
48. Schnall MD, Lenkinski RE, Pollack HM, Imai Y, Kressel HY (1989) Prostate: MR imaging with an endorectal surface coil. Radiology 172:570-574
49. Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P, Carroll PR (1994) Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 193:703-709
50. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: A meta-analysis. Eur Radiol 12:2294-2302
51. Jager GJ, Severens JL, Thornbury JR, de La Rosette JJ, Ruijs SH, Barentsz JO (2000) Prostate cancer staging: Should MR imaging be used? A decision analytic approach. Radiology 215:445-451
52. Harris RD, Schned AR, Heaney JA (1995) Staging of prostate cancer with endorectal MR imaging: Lessons from a learning curve. Radiographics 15:813-829
53. Padhani AR, Mac Vicar AD, Gapinski CJ, Dearnaley DP, Parker GJM, Suckling J, Leach MO, Husband JE (2001) Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 218:365-374
54. D'Amico AV, Chang E, Garnick M, Kantoff P, Jiroutek M, Tempany CM (1998) Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: A new predictor of tumor response to neoadjuvant androgen suppression therapy. Urology 51:287-292
55. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, Weiss JM, Narayan P, Carroll PR (1995) Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195:385-390
56. Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, Carrol PR, Hricak H (2002) Prostate cancer tumor volume: Measurement with endorectal MR and MR spectroscopic imaging. Radiology 223:91-97
57. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB (2002) Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 16:451-463
58. Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J (1999) Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 213:473-480
59. Yu KK, Scheidler J, Hricak H, Vigneron DB, Zaloudek CJ, Males RG, Nelson SJ, Carroll PR, Kurhanewicz J (1999) Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481-488
60. 3) spatial resolution. Radiology 198:795-805
61. Jager GJ, Ruijter ET, van de Kaa CA, de la Rosette JJ, Oosterhof GO, Thornbury JR, Ruijs SH, Barentsz JO (1997) Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: Correlation with histopathologic results. Radiology 203:645-652
62. Ogura K, Maekawa S, Okubo K, Aoki Y, Okada T, Oda K, Watanabe Y, Tsukayama C, Arai Y (2001) Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: Correlation with histopathologic results. Urology 57:721-726
63. Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE (2000) Dynamic contrast enhanced MRI of prostate cancer: Correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55:99-109
64. Preziosi P, Orlachio A, Giambattista GD, Renzi PD, Bortolotti L, Fabiano A, Cruciani E, Pasqualetti P (2003) Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol 13:925-930
65. Rouvière O, Raudrant A, Ecochard R, Colin-Pangaud C, Pasquiou C, Bouvier R, Maréchal JM, Lyonnet D (2003) Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol 13:931-942
66. Schlemmer HP, Merkle J, Grobholz R, Jaeger T, Michel MS, Werner A, Rabe J, van Kaick G (2004) Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol. 14:309-317
67. Huisman HJ, Engelbrecht MR, Barentsz JO (2001) Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 13:607-614
68. Helbich TH, Gossman A, Mareski PA, Raduchel B, Roberts TP, Shames DM, Muhler M, Turetschek K, Brasch RC (2000) A new polysaccharide, macromolecular contrast agent for MR imaging: Biodistribution and imaging characteristics. J Magn Reson Imaging 11:694-701
69. Ophir J, Cespedes I, Ponekanti H, Yazdi Y, Li X (1991) Elastography: A quantitative method for imaging the elasticity of biologic tissues. Ultrason Imaging 13:111-134
70. Muthupillai R, Lomas DJ, Rossman PJ, Greanleaf JF, Manduca A, Ehman RL (1995) Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 26:1854-1857
71. Purohit RS, Shinohara K, Meng MV, Carroll PR (2003) Imaging clinically localized prostate cancer. Urol Clin North Am 30:279-293
72. Cochlin DL, Ganatra RH, Griffiths DF (2002) Elastography in the detection of prostatic cancer. Clin Radiol 57:1014-1020
73. Sommerfeld HJ, Garcia-Schurmann JM, Schewe J, Kuhne K, Cubick F, Berges RR, Lorenz A, Pesavento A, Scheipers S, Ermert H, Pannek J, Philippou S, Senge T (2003) Prostate cancer diagnosis using ultrasound elastography. Introduction of a novel technique and first clinical results. Urologe A 42:941-945
74. Manduca A, Oliphant TE, Dresner MA, Mahowald JL, Kruse SA, Amromin E, Felmlee JP, Greenleaf JF, Ehman RL (2001) Magnetic resonance elastography: Non-invasive mapping of tissue elasticity. Med Image Anal 5:237-254